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We describe a family of 32 subjects, including two healthy siblings without detectable pancreatic amyiase in serum and five healthy relatives (one of them a sister) exhibiting subnormal pancreatic amylase activities. Comparisons of immunoreactive amylase concentrations with the corresponding amylase activities may justify the assumption of a "silent" Amy-2 allelic variant.
Additional Keyphrases: immunoreactive amylase heritable disorders
Human a-amylases (EC 3.2.1.1) are synthesized from two closely related structural genes (1) on chromosome no. 1, Amy-i (nonpancreatic amylase) and Amy-2 (pancreatic amylase). In healthy individuals the pancreatic type will constitute about half of the total amylase activity in serum. Generally, a diminished activity of the pancreatic amylase in serum is supposed to reflect a decreased exocrine pancreatic function.
Case Report
We accidentally discovered the case of a healthy woman, age 26 years, with an extremely low (<10 U/L) serum pancreatic amylase activity [method: electrophoresis in agarose gel (2, 3), pH 8.6; reference interval: 40-150 UIL; precision: 5 U/L]. The findings were confirmed by measurements repeated haifa year later. From information provided by the proband a pedigree was constructed, and 32 of 33 subjects older than 10 years (siblings, parents, parental siblings, cousins, and cousins' children) were interviewed and blood tested. The pedigree and the results for total amylase activity, pancreatic amylase activity, and concentration of iminunoreactive trypsin were published in an earlier paper (4) .
Besides the proband, her healthy brother, age 37 years, also exhibited a pancreatic amylase activity <10 U/L in serum. Their only sister, healthy and 35 years old, showed a subnormal serum pancreatic amylase activity (38 U/L). father's, a daughter of a mother's sister, and a son of hers) exhibited low activities of serum pancreatic amylase (24-38 UIL). All seven subjects with subnormal pancreatic amylase activity showed normal concentrations of immunoreactive trypsin (reference interval: 140-400 g/L) in serum, which was taken as an indication of an unimpaired exocrine pancreatic function (5) . Of the 32 persons studied, 31 had values for total serum amylase activity within the reference interval (70-300 UIL, Phadebas, 37#{176}C). One subject, a man 22 years of age, had a total amylase activity of 414 U/L and a concentration of immunoreactive trypsin >1300 ig/L. Since our first communication (4) an ELISA assay for quantification of immunoreactive amylase has been developed (3). This assay, based on polyclonal rabbit antibodies raised against a highly purified human amylase Thus, the unimpaired relationship between catalytic activity and concentration of immunoreactive amylase in the blood samples from the two siblings without detectable pancreatic amylase and from their five relatives with low activity of pancreatic amylase might reflect a "silent" Amy-2 allelic variant (not previously reported) rather than the presence of a noncatalytic gene product. However, two other theories may also explain the observed phenomenon: (a) pancreatic amylase may for some unknown reason fail to enter the vascular system or (b) the blood may contain an Amy-2 amylase that cannot be resolved from the Amy-i amylase forms by the methods we used.
Neither of the two (homozygotic?) persons without detectable serum pancreatic amylase activity showed any clinical symptoms of impaired carbohydrate digestion, which is not necessarily a concomitant (7) , and both of them refused further investigations.
Therefore, duodenal aspirates were not available, and we were not able to make more conclusive studies.
